IPO Plus

2,178.7

-10.07 -0.46%

As of 21 Sept 2026 · delayed

NSE Listed · Healthcare

Hester Biosciences Limited (HESTERBIO)

Volume: 3,22752W Range:1,239.32,683.6
Key Ratios
Checked 3h ago
Market Cap₹1,853 Cr
Current Price₹2,178.7
Previous Close₹2,188.77
High / Low (52w)₹2,683.6 / ₹1,239.3
Volume3,227
Avg Vol (1W)
Avg Vol (1M)
Stock P/E13.73
Book Value₹423.46
Dividend Yield50%
ROE15.45%
ROA20.2%
Revenue (TTM)
Revenue Growth
Profit Margin
Total Debt₹133 Cr
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹158.69
P/B5.14
Debt / Equity52.96
50 DMA₹2,380.38
200 DMA₹1,841.35
Day change-0.46%
Price Chart
2,178.7 9.66% · 1Y
252313124.5L
2025-09-22
2026-09-21

20-day avg volume: 9K shares

Pros
  • Healthy return on equity of 15.4%.
  • Pays a dividend yield of 50.0%.
  • Net profit is growing year over year.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹84 Cr₹63 Cr₹82 Cr₹84 Cr₹71 Cr₹77 Cr₹100 Cr₹77 Cr
EBITDA₹17 Cr₹9 Cr₹8 Cr₹21 Cr₹17 Cr₹14 Cr₹25 Cr₹17 Cr
Net Profit₹8 Cr₹12 Cr₹1 Cr₹16 Cr₹14 Cr₹9 Cr₹16 Cr₹97 Cr
EPS
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹315 Cr₹77 Cr₹63 Cr₹65 Cr₹70 Cr₹94 Cr₹342 Cr₹73 Cr
EBITDA₹48 Cr₹13 Cr₹11 Cr₹11 Cr₹16 Cr₹32 Cr₹77 Cr₹21 Cr
Net Profit₹27 Cr₹10 Cr₹8 Cr₹7 Cr₹11 Cr₹26 Cr₹56 Cr₹15 Cr
EPS33.8967.57
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹299 Cr₹387 Cr₹411 Cr₹562 Cr₹670 Cr₹662 Cr₹653 Cr₹678 Cr
Total Liabilities₹118 Cr₹180 Cr₹175 Cr₹295 Cr₹381 Cr₹359 Cr₹327 Cr₹310 Cr
Equity₹181 Cr₹206 Cr₹236 Cr₹267 Cr₹289 Cr₹303 Cr₹327 Cr₹368 Cr
Total Debt
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹64 Cr₹48 Cr₹72 Cr₹26 Cr₹32 Cr₹60 Cr₹76 Cr₹78 Cr
Investing₹-23 Cr₹-74 Cr₹-38 Cr₹-117 Cr₹-77 Cr₹-23 Cr₹-19 Cr₹-3 Cr
Financing₹3 Cr₹19 Cr₹-18 Cr₹112 Cr₹42 Cr₹-26 Cr₹-52 Cr₹-49 Cr
Free Cash Flow₹41 Cr₹-26 Cr₹31 Cr₹-70 Cr₹-46 Cr₹35 Cr₹55 Cr₹60 Cr
Shareholding
Promoter 68.78% Institutions 0.22% Public 31%
About Hester Biosciences Limited

Healthcare · Drug Manufacturers - Specialty & Generic

Hester Biosciences Limited manufactures and trades in veterinary vaccines and health products in India and internationally. It operates through two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis. It also offers vaccines for peste des petits ruminants, goat pox, brucella, lumpy skin disease, contagious bovine pleuropneumonia, and contagious caprine pleuropneumonia for cattle, buffalo, sheep, and goats; and diagnostic services. In addition, the company provides animal healthcare products, such as biosecurity solutions, therapeutics, nutritional supplements, and specialised formulations to enhance animal wellness and productivity. Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticides, grooming products, and anti-infective formulations; and healthcare products, such as immune boosters, gut health enhancers, farm hygiene, vitamins, minerals, and specialty feed supplements for critical needs comprising disease prevention, growth, and nutritional balance. Additionally, the company provides Silvectant, a hydrogen peroxide and silver nitrate solution for disinfection of poultry sheds; Hestbac, a probiotic supplement to control pathogenic bacteria; Hestflora, a combined probiotic and prebiotic formulation that supports gut health and performance; AmmoStop, a probiotic blend for odour control and respiratory comfort in poultry farms. It also offers INACTIVATED H9N2 vaccine for low pathogenic avian influenza; ICEFT RTU, a ceftiofur formulation for uterine and bacterial infections; and Inomilk Gel, an oral calcium supplement, as well as operates diagnostic labs for poultry. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Mehsana, India.

www.hester.in
Efficiency & Working Capital
ROCE14.3%
Interest Coverage7.9
Dividend Payout
Debtor Days105 d
Inventory Days80 d
Payable Days27 d
Cash Conversion Cycle157 d
Working Capital Days184 d
Shareholding Details

As of 2026-06-30

Promoter53.7%
FII0.3%
DII0%
Institutions0.3%
Public46%
Promoter Pledge0%
No. of Shareholders11,961
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters53.7%53.7%53.7%53.7%53.7%53.7%53.7%53.7%53.7%53.7%53.7%53.7%
FIIs0.4%0.4%0.4%0.5%0.6%0.6%0.9%0.5%0.5%0.5%0.4%0.3%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public45.8%45.8%45.8%45.7%45.6%45.7%45.4%45.7%45.7%45.7%45.9%46%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders13,34213,45012,84411,30511,53811,47311,85311,81012,26012,60312,37311,961
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
Rajiv Dinesh GandhiShareholding of Promoter and Promoter Group10.5%8,91,508
Sanjiv Dinesh GandhiShareholding of Promoter and Promoter Group8.2%6,97,820
Nina Rajiv GandhiShareholding of Promoter and Promoter Group8.2%6,96,340
Shaila Bhupendra GandhiShareholding of Promoter and Promoter Group5.8%4,91,300
Ravin GandhiShareholding of Promoter and Promoter Group4.7%4,03,320
Bela GandhiShareholding of Promoter and Promoter Group4.7%4,00,635
Bhupendra Vithaldas GandhiShareholding of Promoter and Promoter Group4.7%3,97,989
Kuntal Hasmukhlal ShahPublic Shareholding3.2%2,69,897
Biolink Healthcare LimitedShareholding of Promoter and Promoter Group2.9%2,48,838
Manish JainPublic Shareholding2.9%2,45,248
Anup Chandravadan KapadiaShareholding of Promoter and Promoter Group2.7%2,28,354
Darshna Dinesh KapadiaPublic Shareholding1.8%1,53,600
Sandeep Shantilal GalaPublic Shareholding1.3%1,10,942
Vinay ShahPublic Shareholding1.3%1,08,900
Manish Jain (huf)Public Shareholding1.2%1,04,869
Jagrut Prataprai GandhiPublic Shareholding1.2%1,00,000
Manish Prataprai GandhiPublic Shareholding1.2%1,00,001
Hester Coatings LlpShareholding of Promoter and Promoter Group0.8%64,000
Hester Diagnostics Private LimitedShareholding of Promoter and Promoter Group0.3%24,000
Hetal Sanjiv GandhiShareholding of Promoter and Promoter Group0.2%19,590
Yash Rajiv GandhiShareholding of Promoter and Promoter Group0.1%7,250
Bhupendra Vithaldas Gandhi HufShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Bhupendra V GandhiChairman & Non Executive Dir.2026
Rajiv D GandhiED / MD / CEO / Promoter2026
PRIYA RAJIV GANDHIExecutive Director2026
Sanjiv D GandhiNon Executive Director2026
Sandhya PatelIndependent Non Exe. Director2026
Ashok BhadakalIndependent Non Exe. Director2026
Ameet DesaiIndependent Non Exe. Director2026
Anil JainIndependent Non Exe. Director2026
Jatin Yagneshbhai TrivediIndependent Non Exe. Director2026
Vinod MaliCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
Poultry Healthcare₹206 Cr70.6%
Animal Healthcare₹86 Cr29.4%
Segments — Geography
RegionRevenueShare
In India₹261 Cr89.4%
Outside India₹31 Cr10.6%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹101199
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-30Board Meetings
forthcoming2026-07-14Dividend (11/- per share)Final
dividend2026-07-14₹11 (110%)Final
dividend2025-08-06₹7 (70%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202634007344
202625007334
2026900009
Insider / Designated-Person Trades

2 recent disclosure(s)

RAJIV DINESH GANDHIAcquisition · 1,111
BHUPENDRA VITHALDAS GANDHIDisposal · 1,111
Substantial Acquisitions (SAST)

1 disclosure(s)

Market29/01/2024 · 10,000
Company Information
Incorporated1987
ChairmanBhupendra V Gandhi
AuditorChandulal M Shah & Co
Investor Email[email protected]
🌐 www.hester.in

📍 1st Flr PushpakPachvati Circle, Motilal Hirabhai Road, Ahmedabad, Gujarat, 380006

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search

Telegram App